2023 Archives - OptikNow

Opti Resumes Usual Dates for 2023

Friday, January 14 2022 | 17 h 23 min | Events, News, Press Release

opti 2023 will once again be held in its usual spot at the start of the industry's year, from January 27 to 29 The 2023 event will also mark the ...

4th World Congress of Optometry Postponed Until 2023

Thursday, September 10 2020 | 16 h 17 min | Events, News, Press Release

The World Council of Optometry (WCO) has announced that the 4th World Congress of Optometry (WCO4) planned for Melbourne, Australia in 2021, will...

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

Visioneering Technologies, Inc, producer of the NaturalVue® Multifocal 1 Day Contact Lenses (NVMF), continued its release of the 1-year prospective data of its ongoing multi-center, randomized, double-masked, controlled trial (RCT) at the Association for Research in Vision and Ophthalmology (ARVO).

Learn More

Voila Optik March-April 2024 GIGI STUDIOS Hilary

New Gradient and Lighter Acetate

GIGI STUDIOS presents HILARY (6889/0), a design crafted from high-quality Italian acetate.

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

In time for Vision Health Month this May, the Canadian Ophthalmological Society (COS) has released a new survey to assess Canadians’ awareness, understanding, and concerns around eye and vision health.

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

Marcolin and K-Way®, French brand born in 1965 – currently owned by Turin-based group BasicNet – and known worldwide for its revolutionary rain jackets, announce they have signed an exclusive licensing agreement.

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

Company Highlights Scientific Program Slated for Annual Meeting in Seattle

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

Learn More

New Gradient and Lighter Acetate

GIGI STUDIOS presents HILARY (6889/0), a design crafted from high-quality Italian acetate.

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

Company Highlights Scientific Program Slated for Annual Meeting in Seattle

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

Learn More

New Gradient and Lighter Acetate

GIGI STUDIOS presents HILARY (6889/0), a design crafted from high-quality Italian acetate.

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

Company Highlights Scientific Program Slated for Annual Meeting in Seattle

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

Learn More

New Gradient and Lighter Acetate

GIGI STUDIOS presents HILARY (6889/0), a design crafted from high-quality Italian acetate.

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

Company Highlights Scientific Program Slated for Annual Meeting in Seattle

Tag: 2023

Opti Resumes Usual Dates for 2023

4th World Congress of Optometry Postponed Until 2023

Featured Posts

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

New Gradient and Lighter Acetate

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

New Gradient and Lighter Acetate

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

New Gradient and Lighter Acetate

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

New Gradient and Lighter Acetate

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort